市場調查報告書

注射式藥物輸送設備的全球市場:各設備·各治療領域·利用模式·注射部位·各流通管道·各利用設施·各地區 - 未來預測

Injectable Drug Delivery Devices Market Information by By Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery, By Distribution Channel, By Facility of Use and By Region - Global Forecasts till 2023

出版商 Market Research Future 商品編碼 801108
出版日期 內容資訊 英文 164 Pages
訂單完成後即時交付
價格
Back to Top
注射式藥物輸送設備的全球市場:各設備·各治療領域·利用模式·注射部位·各流通管道·各利用設施·各地區 - 未來預測 Injectable Drug Delivery Devices Market Information by By Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery, By Distribution Channel, By Facility of Use and By Region - Global Forecasts till 2023
出版日期: 2019年01月31日內容資訊: 英文 164 Pages
簡介

本報告提供全球注射型藥物輸送設備的市場相關分析,提供產品概要和市場基本結構,主要的推動及阻礙市場要素,整體市場趨勢預測 (過去3年·今後6年份),各設備·各治療領域·利用模式·注射部位·各流通管道·各利用設施·各地區的詳細趨勢,市場佔有率結構,主要企業的簡介·業績·策略等調查。

第1章 序論

第2章 分析概要

第3章 分析方法

第4章 市場動態

  • 簡介
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 宏觀經濟指標
  • 市場趨勢
    • 過敏治療自動注射器的利用增加

第5章 市場要素分析

  • 價值鏈分析
    • 研究開發 (R&D),設計
    • 製造
    • 流通·銷售
    • 售後服務
  • 波特的五力分析
  • 投資機會
  • 價格分析
  • 需求與供給:差距分析

第6章 全球注射型藥物輸送設備市場:各設備

  • 簡介
  • 傳統的輸液設備
  • 自我輸液設備

第7章 全球注射型藥物輸送設備市場:各治療領域

  • 簡介
  • 自體免疫疾病
  • 荷爾蒙障礙
  • 癌症

第8章 全球注射型藥物輸送設備市場:利用模式別

  • 簡介
  • 治療
  • 疫苗接種

第9章 全球注射型藥物輸送設備市場:注射部位別

  • 簡介
  • 肌肉注射器
  • 皮下注射器
  • 皮內注射器

第10章 全球注射型藥物輸送設備市場:各流通管道

  • 簡介
  • 醫院·零售藥局
  • 線上·平台

第11章 全球注射型藥物輸送設備市場:各利用設備

  • 簡介
  • 醫院·診療所
  • 家庭治療

第12章 全球注射型藥物輸送設備市場:各地區

  • 簡介
  • 南北美洲 (北美 (美國,加拿大),南美)
  • 歐洲 (西歐 (德國,英國,法國,義大利,西班牙等),東歐)
  • 亞太地區 (日本,中國,印度,韓國,澳洲等)
  • 中東·非洲

第13章 競爭環境

第14章 企業簡介

  • Eisai
    • 企業概要
    • 主要的財務指標
    • 主要產品/服務
    • 近幾年的主要趨勢
    • SWOT分析
    • 主要策略
  • Antares Pharma
  • AstraZeneca
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson Services Inc.
  • Mylan N.V.
  • Novartis AG
  • Novo Nordisk
  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
  • Inovio Pharmaceuticals Inc.

第15章 附錄

目錄

Injectable Drug Delivery Devices Market Information by By Devices (Conventional Injection Devices, Self-Injection Devices), By Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Cancer), By Usage Pattern (Curative pattern, Immunization), By Site of Delivery (Intramuscular, Subcutaneous, Intradermal), By Distribution Channel (Hospital & Retail Pharmacies, Online platforms), By Facility of Use (Hospitals and Clinics, Home Care Settings) and By Region - Global Forecasts till 2023

Market analysis

Advances in technology and innovation are permitting their use in progressively complex delivery systems. A range of gadgets fall under the section of injectable drug delivery devices including needle-free injectors, auto and pen injectors and conventional syringes. Interest for such gadgets has kept on expanding lately as they are being utilized to treatment of ailments that seeing a high rate of prevalence. Presentation of cutting edge gadgets with predominant functional abilities is positively affecting the global injectable drug delivery devices market. Other factor that can be connected with the market's development incorporate expanding pervasiveness of interminable sicknesses, developing appropriation of self-injectable gadgets, and rising FDA endorsements. The market has recorded the growth rate of 11.5% during the forecast period (2018-2023).

Market segmentation

Based on its devices, the global injectable drug delivery devices market is divided into self-injection and conventional injection devices. On the basis of its therapeutic application, the market is sectioned as cancer, hormonal disorders and autoimmune diseases. By usage pattern, it is classified as immunization and curative pattern. Based on its site of delivery, the market is segmented as subcutaneous, intramuscular and intradermal. By facility of use, the market is divided as hospital and retail pharmacies and online platforms. Based on its facility of use, the market is categorized into home care settings and hospitals and clinics.

Regional analysis

Geographically, the global injectable drug delivery devices market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Becton, Dickinson and Company, Eli Lilly and Company, F.Hoffmann-La Roche AG, Eisai Co., Ltd., Antares Pharma, AstraZeneca, among others are the major players in the global injectable drug delivery devices market.

Table of Contents

1 Report Prologue

2 Market Introduction

  • 2.1 Scope of Study
  • 2.2 Research Objective
  • 2.3 List of Assumptions

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Increasing prevalence of chronic diseases
    • 4.2.2 Growing adoption of self-injectable devices
    • 4.2.3 Rising FDA approvals
    • 4.2.4 Drivers Impact Analysis
  • 4.3 Restraints
    • 4.3.1 Risks of cross-contamination
    • 4.3.2 Increasing cost of high-end products
    • 4.3.3 Restraints Impact Analysis
  • 4.4 Opportunity
    • 4.4.1 Increasing campaigns of vaccination in developing economies of the Asia-Pacific region
  • 4.5 Macroeconomic Indicators
  • 4.6 Market Trend
    • 4.6.1 Increasing use of auto-injectors against allergies

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 R&D and Designing
    • 5.1.2 Manufacturing
    • 5.1.3 Distribution & Sales
    • 5.1.4 Post-Sales Review
  • 5.2 Porter's Five Forces Model
    • 5.2.1 Threat of New Entrants
    • 5.2.2 Bargaining Power of Suppliers
    • 5.2.3 Threat of Substitutes
    • 5.2.4 Bargaining Power of Buyers
    • 5.2.5 Intensity of Rivalry
  • 5.3 Investment Opportunities
  • 5.4 Pricing Analysis
  • 5.5 Demand & Supply: Gap Analysis

6 Global Injectable Drug Delivery Devices Market, By Devices

  • 6.1 Introduction
  • 6.2 Conventional Injection Devices
  • 6.3 Self-Injection Devices

7 Global Injectable Drug Delivery Devices Market, By Therapeutic Application

  • 7.1 Introduction
  • 7.2 Autoimmune Diseases
  • 7.3 Hormonal Disorders
  • 7.4 Cancer

8 Global Injectable Drug Delivery Devices Market, By Usage Pattern

  • 8.1 Introduction
  • 8.2 Curative pattern
  • 8.3 Immunization

9 Global Injectable Drug Delivery Devices Market, By Site of Delivery

  • 9.1 Introduction
  • 9.2 Intramuscular
  • 9.3 Subcutaneous
  • 9.4 Intra Dermal

10 Global Injectable Drug Delivery Devices Market, By Distribution Channel

  • 10.1 Introduction
  • 10.2 Hospital & Retail Pharmacies
  • 10.3 Online Platforms

11 Global Injectable Drug Delivery Devices Market, By Facility of Use

  • 11.1 Introduction
  • 11.2 Hospitals and Clinics
  • 11.3 Home Care Settings

12 Global Injectable Drug Delivery Devices Market, By Region

  • 12.1 Introduction
  • 12.2 Americas
    • 12.2.1 North America
      • 12.2.1.1 U.S
      • 12.2.1.2 Canada
      • 12.2.1.3 South America
  • 12.3 Europe
    • 12.3.1 Western Europe
      • 12.3.1.1 Germany
      • 12.3.1.2 U.K
      • 12.3.1.3 France
      • 12.3.1.4 Italy
      • 12.3.1.5 Spain
      • 12.3.1.6 Rest of Western Europe
    • 12.3.2 Eastern Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Republic of Korea
    • 12.4.5 Australia
    • 12.4.6 Rest of Asia Pacific
  • 12.5 Middle East & Africa
    • 12.5.1 Middle East
    • 12.5.2 Africa

13 Competitive Landscape

  • 13.1 Introduction

14 Company Profile

  • 14.1 Eisai Co., Ltd.
    • 14.1.1 Company Overview
    • 14.1.2 Financial Overview
    • 14.1.3 Products Offering
    • 14.1.4 Key Developments
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Strategy
  • 14.2 Antares Pharma
    • 14.2.1 Company Overview
    • 14.2.2 Financial Overview
    • 14.2.3 Products Offering
    • 14.2.4 Key Developments
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Strategy
  • 14.3 AstraZeneca
    • 14.3.1 Company Overview
    • 14.3.2 Financial Overview
    • 14.3.3 Pipeline Products
    • 14.3.4 Key Developments
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Strategy
  • 14.4 Becton, Dickinson and Company
    • 14.4.1 Company Overview
    • 14.4.2 Financial Overview
    • 14.4.3 Products Offering
    • 14.4.4 Key Developments
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Strategy
  • 14.5 Eli Lilly and Company
    • 14.5.1 Company Overview
    • 14.5.2 Financial Overview
    • 14.5.3 Products Offering
    • 14.5.4 Key Developments
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Strategy
  • 14.6 F. Hoffmann-La Roche AG
    • 14.6.1 Company Overview
    • 14.6.2 Financial Overview
    • 14.6.3 Products Offering
    • 14.6.4 Key Developments
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Strategy
  • 14.7 Johnson & Johnson Services Inc.
    • 14.7.1 Company Overview
    • 14.7.2 Financial Overview
    • 14.7.3 Products Offering
    • 14.7.4 Key Developments
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Strategy
  • 14.8 Mylan N.V.
    • 14.8.1 Company Overview
    • 14.8.2 Financial Overview
    • 14.8.3 Products Offering
    • 14.8.4 Key Developments
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Strategy
  • 14.9 Novartis AG
    • 14.9.1 Company Overview
    • 14.9.2 Financial Overview
    • 14.9.3 Products Offering
    • 14.9.4 Key Developments
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Strategy
  • 14.1 Novo Nordisk
    • 14.10.1 Company Overview
    • 14.10.2 Financial Overview
    • 14.10.3 Products Offering
    • 14.10.4 Key Developments
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Strategy
  • 14.11 Pfizer Inc.
    • 14.11.1 Company Overview
    • 14.11.2 Financial Overview
    • 14.11.3 Products Offering
    • 14.11.4 Key Developments
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Strategy
  • 14.12 Sanofi
    • 14.12.1 Company Overview
    • 14.12.2 Financial Overview
    • 14.12.3 Products Offering
    • 14.12.4 Key Developments
    • 14.12.5 SWOT Analysis
    • 14.12.6 Key Strategy
  • 14.13 Teva Pharmaceutical Industries Ltd
    • 14.13.1 Company Overview
    • 14.13.2 Financial Overview
    • 14.13.3 Products Offering
    • 14.13.4 Key Developments
    • 14.13.5 SWOT Analysis
    • 14.13.6 Key Strategy
  • 14.14 Inovio Pharmaceuticals Inc.
    • 14.14.1 Company Overview
    • 14.14.2 Financial Overview
    • 14.14.3 Products Offering
    • 14.14.4 Key Developments
    • 14.14.5 SWOT Analysis
    • 14.14.6 Key Strategy

15 Appendix

  • 15.1 Discussion Blue Print

List of Tables

  • TABLE 1 LIST OF ASSUMPTIONS
  • TABLE 2 PRIMARY INTERVIEWS
  • TABLE 3 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 4 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR CONVENTIONAL INJECTION DEVICES BY REGION 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR SELF-INJECTION DEVICES BY REGION 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2015-2023 (USD MILLION)
  • TABLE 11 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR AUTOIMMUNE DISEASES BY REGION 2015-2023 (USD MILLION)
  • TABLE 12 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HORMONAL DISORDERS BY REGION 2015-2023 (USD MILLION)
  • TABLE 13 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR CANCER BY REGION 2015-2023 (USD MILLION)
  • TABLE 14 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 15 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR CURATIVE PATTERN BY REGION 2015-2023 (USD MILLION)
  • TABLE 16 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR IMMUNIZATION BY REGION 2015-2023 (USD MILLION)
  • TABLE 17 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 18 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR INTRAMUSCULAR BY REGION 2015-2023 (USD MILLION)
  • TABLE 19 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR SUBCUTANEOUS BY REGION 2015-2023 (USD MILLION)
  • TABLE 20 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR INTRA DERMAL BY REGION 2015-2023 (USD MILLION)
  • TABLE 21 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 22 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HOSPITAL & RETAIL PHARMACIES BY REGION 2015-2023 (USD MILLION)
  • TABLE 23 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR ONLINE PLATFORMS BY REGION 2015-2023 (USD MILLION)
  • TABLE 24 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 25 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HOSPITALS AND CLINICS BY REGION 2015-2023 (USD MILLION)
  • TABLE 26 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, FOR HOME CARE SETTINGS BY REGION 2015-2023 (USD MILLION)
  • TABLE 27 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 28 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 29 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 30 AMERICAS SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 31 AMERICAS CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 32 AMERICAS CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 33 AMERICAS CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 34 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 35 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 36 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 37 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 38 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 39 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 40 NORTH AMERICA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 41 NORTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 42 NORTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 43 NORTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 44 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 45 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 46 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 47 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 48 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 49 U.S INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 50 U.S SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 51 U.S CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 52 U.S CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 53 U.S CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 54 U.S INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 55 U.S INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 56 U.S INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 57 U.S INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 58 U.S INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 59 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 60 CANADA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 61 CANADA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 62 CANADA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 63 CANADA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 64 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 65 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 66 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 67 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 68 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 69 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 70 SOUTH AMERICA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 71 SOUTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 72 SOUTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 73 SOUTH AMERICA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 74 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 75 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 76 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 77 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 78 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 79 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 80 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 81 EUROPE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 82 EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 83 EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 84 EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 85 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 86 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 87 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 88 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 89 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 90 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY 2015-2023 (USD MILLION)
  • TABLE 91 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 92 WESTERN EUROPE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 93 WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 94 WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 95 WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 96 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 97 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 98 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 99 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 100 WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 101 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 102 GERMANY SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 103 GERMANY CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 104 GERMANY CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 105 GERMANY CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 106 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 107 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 108 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 109 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 110 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 111 U.K INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 112 U.K SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 113 U.K CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 114 U.K CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 115 U.K CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 116 U.K INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 117 U.K INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 118 U.K INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 119 U.K INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 120 U.K INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 121 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 122 FRANCE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 123 FRANCE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 124 FRANCE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 125 FRANCE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 126 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 127 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 128 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 129 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 130 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 131 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 132 ITALY SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 133 ITALY CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 134 ITALY CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 135 ITALY CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 136 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 137 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 138 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 139 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 140 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 141 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 142 SPAIN SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 143 SPAIN CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 144 SPAIN CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 145 SPAIN CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 146 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 147 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 148 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 149 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 150 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 151 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 152 REST OF WESTERN EUROPE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 153 REST OF WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 154 REST OF WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 155 REST OF WESTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 156 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 157 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 158 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 159 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 160 REST OF WESTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 161 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 162 EASTERN EUROPE SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 163 EASTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 164 EASTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 165 EASTERN EUROPE CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 166 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 167 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 168 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 169 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 170 EASTERN EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 171 ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY 2015-2023 (USD MILLION)
  • TABLE 172 ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 173 ASIA PACIFIC SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 174 ASIA PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 175 ASIA PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 176 ASIA PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 177 ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 178 ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 179 ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 180 ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 181 ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 182 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 183 JAPAN SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 184 JAPAN CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 185 JAPAN CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 186 JAPAN CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 187 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 188 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 189 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 190 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 191 JAPAN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 192 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 193 CHINA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 194 CHINA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 195 CHINA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 196 CHINA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 197 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 198 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 199 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 200 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 201 CHINA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 202 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 203 INDIA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 204 INDIA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 205 INDIA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 206 INDIA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 207 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 208 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 209 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 210 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 211 INDIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 212 REPUBLIC OF KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 213 REPUBLIC OF KOREA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 214 REPUBLIC OF KOREA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 215 REPUBLIC OF KOREA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 216 REPUBLIC OF KOREA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 217 REPUBLIC OF KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 218 REPUBLIC OF KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 219 REPUBLIC OF KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 220 REPUBLIC OF KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 221 REPUBLIC OF KOREA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 222 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 223 AUSTRALIA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 224 AUSTRALIA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 225 AUSTRALIA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 226 AUSTRALIA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 227 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 228 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 229 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 230 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 231 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 232 REST OF ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 233 REST OF ASIA PACIFIC SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 234 REST OF ASIA PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 235 REST OF ASIA PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 236 REST OF ASIA PACIFIC CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 237 REST OF ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 238 REST OF ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 239 REST OF ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 240 REST OF ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 241 REST OF ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 242 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 243 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 244 MIDDLE EAST & AFRICA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 245 MIDDLE EAST & AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 246 MIDDLE EAST & AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 247 MIDDLE EAST & AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 248 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 249 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 250 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 251 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 252 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 253 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 254 MIDDLE EAST SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 255 MIDDLE EAST CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 256 MIDDLE EAST CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 257 MIDDLE EAST CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 258 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 259 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 260 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 261 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 262 MIDDLE EAST INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 263 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2015-2023 (USD MILLION)
  • TABLE 264 AFRICA SELF-INJECTION DEVICES MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 265 AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY MATERIAL 2015-2023 (USD MILLION)
  • TABLE 266 AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2023 (USD MILLION)
  • TABLE 267 AFRICA CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2023 (USD MILLION)
  • TABLE 268 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2015-2023 (USD MILLION)
  • TABLE 269 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2015-2023 (USD MILLION)
  • TABLE 270 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • TABLE 271 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 272 AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2015-2023 (USD MILLION)
  • TABLE 273 TOP PLAYERS IN THE GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET

List of Figures

  • FIGURE 1 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET: MARKET STRUCTURE
  • FIGURE 2 RESEARCH PROCESS
  • FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 4 MARKET DYNAMICS: GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET
  • FIGURE 5 DRIVERS IMPACT ANALYSIS: GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET
  • FIGURE 6 RESTRAINTS IMPACT ANALYSIS: GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET
  • FIGURE 7 VALUE CHAIN: GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET
  • FIGURE 8 PORTER'S FIVE FORCES MODEL: GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET
  • FIGURE 9 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DEVICES 2017 & 2023 (USD MILLION)
  • FIGURE 10 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)
  • FIGURE 11 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USAGE PATTERN 2017 & 2023 (USD MILLION)
  • FIGURE 12 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY SITE OF DELIVERY 2017 & 2023 (USD MILLION)
  • FIGURE 13 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 2017 & 2023 (USD MILLION)
  • FIGURE 14 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY FACILITY OF USE 2017 & 2023 (USD MILLION)
  • FIGURE 15 GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET SHARE, BY REGION 2017 (%)
  • FIGURE 16 AMERICAS INJECTABLE DRUG DELIVERY DEVICES MARKET SHARE, BY REGION 2017 (%)
  • FIGURE 17 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET SHARE, BY REGION 2017 (%)
  • FIGURE 18 ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES MARKET SHARE, BY COUNTRY 2017 (%)
  • FIGURE 19 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY DEVICES MARKET SHARE, BY REGION 2017 (%)
Back to Top